Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2659 |
|
| Actual shortage: | 251 (9%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2399 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
329 (11%) |
|
Overdue reports |
27 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-CYCLOSPORINE | 0.05% | EMULSION | Resolved | 2021-07-22 | 2021-09-30 | 142902 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-06-10 | 2021-09-30 | 140675 |
| TEVA-BUPROPION XL | 300MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-16 | 2021-09-30 | 120473 |
| TEVA-METOPROLOL | 25MG | TABLET | Resolved | 2019-12-05 | 2021-09-30 | 100308 |
| TEVA-SILDENAFIL | 25MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145121 |
| TEVA-PROPRANOLOL | 40MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145118 |
| TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-09-02 | 2021-09-23 | 145112 |
| TEVA-5 ASA | 400MG | TABLET (ENTERIC-COATED) | Resolved | 2021-08-27 | 2021-09-23 | 144726 |
| ACT NABILONE | 0.5MG | CAPSULE | Resolved | 2020-04-16 | 2021-09-23 | 112394 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1714 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 500MG | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1729 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1724 |
| TEVA-LORAZEPAM | 0.5MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144752 |
| TEVA-TOPISONE | 0.05% | CREAM | Resolved | 2021-08-27 | 2021-09-16 | 144721 |
| TEVA-BUPRENORPHINE/NALOXONE | 0.5MG 2MG | TABLET | Resolved | 2021-08-27 | 2021-09-16 | 144704 |
| ACT ENALAPRIL | 16MG | TABLET | Resolved | 2021-03-25 | 2021-09-16 | 136283 |
| ACT ENALAPRIL | 8MG | TABLET | Resolved | 2021-02-25 | 2021-09-16 | 134743 |
| TEVA-IRBESARTAN HCTZ | 300MG 25MG | TABLET | Resolved | 2021-06-10 | 2021-09-10 | 140681 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 150MG | TABLET | Resolved | 2019-12-19 | 2021-09-10 | 101725 |
| TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2019-12-05 | 2021-09-10 | 100305 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-FUROSEMIDE | 20MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14039 |
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 500MG | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14014 |
| TEVA-PRAMIPEXOLE | 1.5MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14007 |